Home LiteratureArticle Details
PMID: 7960222 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.

International journal of cancer ·Vol. 59 ·No. 4 ·1994-11-15 ·Pages 514-9

Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P, Qiu SL, Yang CS

Abstract

The objective of this study was to quantify the changes in p53 and cyclin D1 protein levels in different stages of human esophageal and gastric cardia carcinogenesis in a high-risk population in Henan, China. Immunoreactivity of p53, cyclin D1 and proliferating-cell nuclear antigen (PCNA) was observed in the cell nuclei of esophageal and gastric cardia biopsies. The number of p53-immunostaining-positive cells was low in normal epithelia, slightly increased in basal-cell hyperplasia (BCH), markedly increased in dysplasia (DYS) (10-fold), and further increased in squamous-cell carcinoma (SCC) (40-fold). This pattern of change was similar to that of cell proliferation as indicated by PCNA immunostaining. On the other hand, the number of cyclin D1-immunostaining-positive cells did not increase from BCH to DYS, although a slight increase from DYS to SCC was noted. In the gastric cardia, again, the pattern of change of p53-positive cells in different stages of lesions paralleled the pattern of cell proliferation. The number of p53-positive cells was very low, much lower than that of PCNA-positive cells, in normal, chronic superficial gastritis (CSG) and chronic atrophic gastritis (CAG); therefore, the increase of p53-positive cells from CAG to DYS was more dramatic (100-fold). From DYS to adenocarcinoma (AC), the p53-positive and the PCNA-positive cells increased 4-fold. On the other hand, the number of cyclin D1-positive cells did not increase in pre-cancerous lesions, but increased slightly in AC. This study demonstrates that p53 protein accumulation increased with the progression of pre-cancerous lesions, especially in the genesis of dysplasia, both in the esophagus and in the gastric cardia. Our approach of quantitative immunohistochemistry sheds light on the mechanisms of genesis of esophageal and gastric-cardia cancers, which frequently occur together in many high-incidence areas.

MeSH Terms
Adenocarcinoma/chemistry,pathology Adult Aged Biomarkers, Tumor/analysis Carcinoma, Squamous Cell/chemistry,pathology Cardia/chemistry,pathology Cell Division Cell Transformation, Neoplastic/chemistry Chi-Square Distribution Cyclin D1 Cyclins/analysis Esophageal Neoplasms/chemistry,pathology Female Humans Hyperplasia Immunoenzyme Techniques Male Middle Aged Neoplasm Proteins/analysis Neoplasm Staging Oncogene Proteins/analysis Precancerous Conditions/chemistry,pathology Proliferating Cell Nuclear Antigen/analysis Stomach Neoplasms/chemistry,pathology Tumor Suppressor Protein p53/analysis
Chemicals
Biomarkers, Tumor Cyclins Neoplasm Proteins Oncogene Proteins Proliferating Cell Nuclear Antigen Tumor Suppressor Protein p53 Cyclin D1
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Wang L D
Laboratory for Cancer Research, College of Pharmacy, Rutgers University, Piscataway, NJ 08854.
Shi S T
Zhou Q
Goldstein S
Hong J Y
Shao P
Qiu S L
Yang C S
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
1994-11-15
Pages
514-9
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Grants
NCI NIH HHS · CA37037 · United States
NIEHS NIH HHS · ES05022 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]